Adaptive Biotechnologies Corporation (ADPT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Adaptive Biotechnologies Corporation  (NASDAQ: ADPT)


Adaptive Biotechnologies's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Adaptive Biotechnologies's ROI in the second quarter of 2026?
Adaptive Biotechnologies Corporation recorded a cumulative net loss of $-64 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -14.04%.

Within the Healthcare sector 267 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2633 to 3147.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 4.87 % -8.95 % -14.51 % -19.36 % -22.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 561 427 429 407 404
Return On Investment (TTM) -14.04 % -11.91 % -14.3 % -19 % -27.89 %
ADPT's Overall Ranking # 3147 # 2633 # 2502 # 2903 # 3040
Seq. Investment Change TTM 9.38 % 0.24 % -0.72 % -3.66 % -5.04 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -64 -50 -59 -80 -121




Return On Investment ADPT's Ranking
Within: No.
Industry # 28
Sector # 268
Overall # 3147

Return On Investment Statistics
High Average Low
26.43 %
-13.11 %
-35.55 %
(Jun 30 2016)   (Jun 30 2024)







Financial Statements
Adaptive Biotechnologies's II. Quarter Investments $ 561 Millions ADPT's Balance sheet
Adaptive Biotechnologies's II. Quarter Income $ -40 Millions Quarterly ADPT's Income Statement
ADPT's Income by Division See ADPT's Income by Division


ADPT Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 429 441 573 747 810
Y / Y Investment Growth -2.74 % -23.02 % -23.27 % -7.77 % -19.93 %
Net Income in Millions -59 -160 -225 -200 -207
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.86 % -36.18 % -39.32 % -26.83 % -25.6 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADPT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADPT's Competitors
Subscribers only: Roi for Adaptive Biotechnologies's Suppliers
Subscribers only: Return On Investment for ADPT's Customers

Other Ratios
ADPT's Roa ADPT's Inventory Turnover Ratio ADPT's Growth Rates ADPT's Dividend Statistics
ADPT's Profitability Ratios ADPT's Asset Turnover Ratio ADPT's Dividend Growth
ADPT's Roe ADPT's Valuation Ratios ADPT's Financial Strength Ratios ADPT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-12T06:23:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.